Peptide Hydrogels for Delivery of Immunosuppressive Drugs and Uses Thereof
Summary:
The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a hydrogel-based delivery system for the local administration of tofacitinib to improve transplant outcomes.